In Clinical Trial Setting, Survival Is Similar for Black & White Patients With Prostate Cancer
Both Black and White patients with metastatic castration-sensitive prostate cancer (mCSPC) showed similar progression-free survival and overall survival in a clinical trial setting.
Read More